Zackary Falls retweeted
journals.asm.org/doi/10.1128…
Collaborative paper with folks from the CDC published in CMR (IF 22+)
Zackary Falls retweeted
JSMBS News had an article in April 2023 about the $3-$4 million in grants we received in 2022. This is old news but the PR is new. Couldn't have done this without awesome collaborators. Still more news to come...
medicine.buffalo.edu/news_an…
Zackary Falls retweeted
Manuscript showing that the CANDO paradigm works not just for predicting phenotypes (indications and adverse events) but also extracting features responsible for small molecule toxicity. mdpi.com/1420-3049/27/9/3021
Seeking highly motivated and exceptional PhD graduates to pursue ground-breaking Biomedical Informatics research. We have numerous on-going projects, so reach out for more info! @UBInformatics lnkd.in/gQQVmuwv #biomedicalresearch #postdoctoralfellowship
Zackary Falls retweeted
This publication, the second part of v2 of our CANDO platform, was in press for a long time but the final citation just came through. It formed the final chapter of Jim Schuler's thesis: sciencedirect.com/science/ar…
So excited to get this work published!
Exciting new @UBScience from @zfalls and @ZurekThe displaying the innovation and effectiveness of the #XtalOpt software package now published in JPC C.
@UBChemistry #crystalstructureprediction #evolutionaryalgorithms
acspubs.co/W7aR50CCvsE
Zackary Falls retweeted
#cando.py: Open Source Software for Predictive Bioanalytics of Large Scale #Drug–Protein–Disease Data
pubs.acs.org/doi/10.1021/acs…
@willmangione
@zfalls
@absonite
@ram_samudrala
@UBInformatics
#current_issue #application_note
Zackary Falls retweeted
#cando.py: Open Source Software for Predictive Bioanalytics of Large Scale #Drug–Protein–Disease Data
pubs.acs.org/doi/10.1021/acs…
@willmangione @zfalls @absonite @ram_samudrala @UBInformatics
#ASAP
Newest paper from the Samudrala group. CANDO code is available on GitHub and Anaconda. @willmangione @ram_samudrala @UBInformatics @absonite
cando.py: Open Source Software for Predictive Bioanalytics of Large Scale Drug–Protein–Disease Data pubs.acs.org/doi/10.1021/acs…
Shotgun drug repurposing biotechnology to tackle epidemics and pandemi... sciencedirect.com/science/ar…
@willmangione @ram_samudrala @absonite
CTSI Translational Pilot Studies Program awards 13 new grants for 2020-21 shar.es/aHG7NB
Zackary Falls retweeted
Our brief communication on shotgun drug repurposing for #COVIDー19 on chemRxiv led by talented students @willmangione @zfalls in @ram_samudrala group. Looking for wet-lab scientist to test top 20-40 predictions Please RT. Regular prediction updates here - protinfo.compbio.buffalo.edu…
Brief Communication about investment in shotgun drug repurposing tech and CANDO platform applied to COVID-19: doi.org/10.26434/chemrxiv.12…
Zackary Falls retweeted
Brief Communication about investment in shotgun drug repurposing tech and CANDO platform applied to COVID-19: doi.org/10.26434/chemrxiv.12…
Zackary Falls retweeted
#UBuffalo chemist Eva Zurek was on Science Friday!! The topic of conversation? The hunt for room-temperature superconductors. ⚛️⚡ Yep, high-pressure #chemistry is pretty cool (or, shall we say, hot?). Listen to the segment online: sciencefriday.com/segments/t…
Latest paper from the Samudrala Group!!! #drugrepurposing #drugdiscovery #informatics @ram_samudrala @willmangione @DiabetesDataJim @compbiom @UBInformatics @OpenBabel_org
Exploration of interaction scoring criteria in the CANDO platform bmcresnotes.biomedcentral.co…
Zackary Falls retweeted
#Special #Issue "#Computational #Drug #Repurposing". Deadline for manuscript submissions: 31 May 2019. Waiting for your submissions! 😉
More info at: mdpi.com/si/pharmaceutics/co…
Zackary Falls retweeted
Excited for a talk by Dr. Gaurav Chopra @chopralab @RoswellPark @zfalls @willmangione @DiabetesDataJim #MachineLearning #Cancer #Immunotherapy
Zackary Falls retweeted
Dr. Peter Elkin presenting at the @UBuffaloCTSI Workforce Development Core, "Responsible #Data Acquisition and Management." #UBuffalo #CTRC
















